<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Misra, Sanjay</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Cardiovascular Innovations: The Future is Now</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">28-29</style></pages><abstract><style  face="normal" font="default" size="100%">Nanomaterials are materials in which 50% or more of the contained particles are in the range of 1 nm to 100 nm. They have several potential clinical applications, including antithrombotic therapy, cell therapy, treatment of atherosclerosis, drug delivery, and nanorods for induction of angiogenesis. This article discusses the targets and therapies of nanotechnology, next-generation ventricular assist devices, drug-coated balloons and bioabsorbable stents.</style></abstract><number><style face="normal" font="default" size="100%">18</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>